Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Front Mol Biosci
2021 Feb 18;7:598419. doi: 10.3389/fmolb.2020.598419.
Show Gene links
Show Anatomy links
Functional Expression of the Human Glucose Transporters GLUT2 and GLUT3 in Yeast Offers Novel Screening Systems for GLUT-Targeting Drugs.
Schmidl S
,
Tamayo Rojas SA
,
Iancu CV
,
Choe JY
,
Oreb M
.
???displayArticle.abstract???
Human GLUT2 and GLUT3, members of the GLUT/SLC2 gene family, facilitate glucose transport in specific tissues. Their malfunction or misregulation is associated with serious diseases, including diabetes, metabolic syndrome, and cancer. Despite being promising drug targets, GLUTs have only a few specific inhibitors. To identify and characterize potential GLUT2 and GLUT3 ligands, we developed a whole-cell system based on a yeast strain deficient in hexose uptake, whose growth defect on glucose can be rescued by the functional expression of human transporters. The simplicity of handling yeast cells makes this platform convenient for screening potential GLUT2 and GLUT3 inhibitors in a growth-based manner, amenable to high-throughput approaches. Moreover, our expression system is less laborious for detailed kinetic characterization of inhibitors than alternative methods such as the preparation of proteoliposomes or uptake assays in Xenopus oocytes. We show that functional expression of GLUT2 in yeast requires the deletion of the extended extracellular loop connecting transmembrane domains TM1 and TM2, which appears to negatively affect the trafficking of the transporter in the heterologous expression system. Furthermore, single amino acid substitutions at specific positions of the transporter sequence appear to positively affect the functionality of both GLUT2 and GLUT3 in yeast. We show that these variants are sensitive to known inhibitors phloretin and quercetin, demonstrating the potential of our expression systems to significantly accelerate the discovery of compounds that modulate the hexose transport activity of GLUT2 and GLUT3.
Abramson,
The lactose permease of Escherichia coli: overall structure, the sugar-binding site and the alternating access model for transport.
2003, Pubmed
Abramson,
The lactose permease of Escherichia coli: overall structure, the sugar-binding site and the alternating access model for transport.
2003,
Pubmed
Ancey,
Glucose transporters in cancer - from tumor cells to the tumor microenvironment.
2018,
Pubmed
Aseervatham,
The Role of Flexible Loops in Folding, Trafficking and Activity of Equilibrative Nucleoside Transporters.
2015,
Pubmed
,
Xenbase
Augustin,
The protein family of glucose transport facilitators: It's not only about glucose after all.
2010,
Pubmed
Barron,
Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment.
2016,
Pubmed
Boles,
A Growth-Based Screening System for Hexose Transporters in Yeast.
2018,
Pubmed
Brockmann,
The expanding phenotype of GLUT1-deficiency syndrome.
2009,
Pubmed
Bruder,
Parallelised online biomass monitoring in shake flasks enables efficient strain and carbon source dependent growth characterisation of Saccharomyces cerevisiae.
2016,
Pubmed
Carreño,
Fructose and prostate cancer: toward an integrated view of cancer cell metabolism.
2019,
Pubmed
Chow,
Structure of the multigene family of MAL loci in Saccharomyces.
1989,
Pubmed
Colville,
Kinetic analysis of the liver-type (GLUT2) and brain-type (GLUT3) glucose transporters in Xenopus oocytes: substrate specificities and effects of transport inhibitors.
1993,
Pubmed
,
Xenbase
Deng,
Molecular basis of ligand recognition and transport by glucose transporters.
2015,
Pubmed
Fukumoto,
Sequence, tissue distribution, and chromosomal localization of mRNA encoding a human glucose transporter-like protein.
1988,
Pubmed
George Thompson,
Discovery of a specific inhibitor of human GLUT5 by virtual screening and in vitro transport evaluation.
2016,
Pubmed
Gietz,
Frozen competent yeast cells that can be transformed with high efficiency using the LiAc/SS carrier DNA/PEG method.
2007,
Pubmed
Gould,
Expression of a functional glucose transporter in Xenopus oocytes.
1989,
Pubmed
,
Xenbase
Guillemain,
The large intracytoplasmic loop of the glucose transporter GLUT2 is involved in glucose signaling in hepatic cells.
2000,
Pubmed
Hajiaghaalipour,
Modulation of glucose transporter protein by dietary flavonoids in type 2 diabetes mellitus.
2015,
Pubmed
Joost,
The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members (review).
2001,
Pubmed
Jung,
Mouse embryonic stem cells established in physiological-glucose media express the high KM Glut2 glucose transporter expressed by normal embryos.
2013,
Pubmed
Kasahara,
Expression of the rat GLUT1 glucose transporter in the yeast Saccharomyces cerevisiae.
1996,
Pubmed
Kasahara,
Characterization of rat Glut4 glucose transporter expressed in the yeast Saccharomyces cerevisiae: comparison with Glut1 glucose transporter.
1997,
Pubmed
Katagiri,
Replacement of intracellular C-terminal domain of GLUT1 glucose transporter with that of GLUT2 increases Vmax and Km of transport activity.
1992,
Pubmed
Kraft,
Expression, purification, and functional characterization of the insulin-responsive facilitative glucose transporter GLUT4.
2015,
Pubmed
Kwok,
A guide to the design and use of mismatched and degenerate primers.
1994,
Pubmed
Kwon,
Inhibition of the intestinal glucose transporter GLUT2 by flavonoids.
2007,
Pubmed
,
Xenbase
Leandro,
Hexose and pentose transport in ascomycetous yeasts: an overview.
2009,
Pubmed
Lee,
Selected Phytochemicals and Culinary Plant Extracts Inhibit Fructose Uptake in Caco-2 Cells.
2015,
Pubmed
Mueckler,
The SLC2 (GLUT) family of membrane transporters.
2013,
Pubmed
Ohtsubo,
Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes.
2005,
Pubmed
Oldenburg,
Recombination-mediated PCR-directed plasmid construction in vivo in yeast.
1997,
Pubmed
Qureshi,
The molecular basis for sugar import in malaria parasites.
2020,
Pubmed
Santer,
Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome.
1997,
Pubmed
Santer,
The mutation spectrum of the facilitative glucose transporter gene SLC2A2 (GLUT2) in patients with Fanconi-Bickel syndrome.
2002,
Pubmed
Schmidl,
Ligand Screening Systems for Human Glucose Transporters as Tools in Drug Discovery.
2018,
Pubmed
Schmidl,
A label-free real-time method for measuring glucose uptake kinetics in yeast.
2021,
Pubmed
Simpson,
Supply and demand in cerebral energy metabolism: the role of nutrient transporters.
2007,
Pubmed
Simpson,
The facilitative glucose transporter GLUT3: 20 years of distinction.
2008,
Pubmed
Slubowski,
Plasmids for C-terminal tagging in Saccharomyces cerevisiae that contain improved GFP proteins, Envy and Ivy.
2015,
Pubmed
Smirnova,
Outward-facing conformers of LacY stabilized by nanobodies.
2014,
Pubmed
Solis-Escalante,
The genome sequence of the popular hexose-transport-deficient Saccharomyces cerevisiae strain EBY.VW4000 reveals LoxP/Cre-induced translocations and gene loss.
2015,
Pubmed
Thorens,
GLUT2, glucose sensing and glucose homeostasis.
2015,
Pubmed
Tripp,
Establishing a yeast-based screening system for discovery of human GLUT5 inhibitors and activators.
2017,
Pubmed
Uldry,
GLUT2 is a high affinity glucosamine transporter.
2002,
Pubmed
,
Xenbase
Wieczorke,
Characterisation of mammalian GLUT glucose transporters in a heterologous yeast expression system.
2003,
Pubmed
Wieczorke,
Concurrent knock-out of at least 20 transporter genes is required to block uptake of hexoses in Saccharomyces cerevisiae.
1999,
Pubmed
Wu,
Structural insights into assembly and regulation of the plasma membrane phosphatidylinositol 4-kinase complex.
2014,
Pubmed
Wuest,
Molecular Imaging of GLUT1 and GLUT5 in Breast Cancer: A Multitracer Positron Emission Tomography Imaging Study in Mice.
2018,
Pubmed
Yan,
Structural Biology of the Major Facilitator Superfamily Transporters.
2015,
Pubmed
Zamora-León,
Expression of the fructose transporter GLUT5 in human breast cancer.
1996,
Pubmed
Ziegler,
Cellular effects and clinical implications of SLC2A3 copy number variation.
2020,
Pubmed
van 't Klooster,
Periprotein lipidomes of Saccharomyces cerevisiae provide a flexible environment for conformational changes of membrane proteins.
2020,
Pubmed
van 't Klooster,
Membrane Lipid Requirements of the Lysine Transporter Lyp1 from Saccharomyces cerevisiae.
2020,
Pubmed